Clinical trial
Ascorbic Acid Treatment in CMT1A Trial (AATIC)
NCT00271635 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Other · Completed
Key facts
| NCT number | NCT00271635 |
|---|---|
| Title | Ascorbic Acid Treatment in CMT1A Trial (AATIC) |
| Official title | Phase 2 Study of Ascorbic Acid Treatment in Charcot-Marie-Tooth Type 1A |
| Acronym | AATIC |
| Lead sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Charcot-Marie-Tooth Disease, Hereditary Motor and Sensory Neuropathies |
| Intervention type | Drug |
| Interventions | Placebo, ascorbic acid |
| Enrollment | 13 |
| Start date | Jan 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Jan 4, 2006 |
| Last update posted | Jul 4, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: